Featured Articles:

SEC Snares Two “Masterminds” Behind Och-Ziff Bribery Scheme

The SEC recently filed a lengthy civil complaint against two Och-Ziff executives: Michael Cohen, who headed Och-Ziff’s European office, and Vanja Barros, an executive responsible for Africa-related transactions, charging them with participation in a massive bribery scheme in Libya, Chad, Niger, Guinea and the Democratic Republic of Congo. Last year, Och-Ziff settled with the Justice Department and the SEC, and agreed to pay fines and...

Walking the Walk and Talking the Talk – A CEO’s Commitment to Ethics and Compliance

The phrase tone at the top is becoming trite. Compliance professionals use it over and over, and few people explain how to apply the concept.   Speakers and webinar presenters always gloss over tone at the top, emphasizing its importance but providing little practical advice. In some sense, it is hard to define in specific actions since the context and the actors can vary with respect...

The Win-Win Argument: Compliance as a Marketing Advantage

My good friend and colleague Dan Chapman, now the CCO at VimpelCom, is a compliance rock star. I have known Dan for years, beginning when he took over at Parker Drilling and implemented a world-class remediation program to pull Parker Drilling through a difficult FCPA problem. Dan is now heading the effort to remediate and “fix” VimpelCom after the FCPA enforcement action announced last year....

Las Vegas Sands Suffers Double Whammy and Resolves FCPA Action with DOJ for $7 Million

Following a separate SEC action (here), the Justice Department resolved FCPA charges against Las Vegas Sands for $7 million. DOJ and Las Vegas Sands entered into a non-prosecution agreement (NPA) citing much of the same evidence outlined by the SEC in its enforcement action against Las Vegas Sands for $9 million. The Justice Department’s NPA includes a statement of facts centering on large payments made...

Serious Fraud Office Makes Big Splash with UK Bribery Act Resolution with Rolls Royce

After years of fits and starts, and promises and disappointments, the Serious Fraud Office and the UK Bribery Act made its initial splash on the anti-corruption enforcement landscape. Since 2011, companies have been warned that the SFO would begin enforcing the UK Bribery Act. There have been a few enforcement actions and important legal modifications in the UK authorizing deferred prosecution agreements. While it has...

C-Suite Misconduct Results in Sociedad Quimica Y Minera FCPA Resolution with DOJ and SEC

In an unusual FCPA enforcement action, the Justice Department and the SEC resolved FCPA violations against Sociedad Quimica y Minera, a Chilean chemical and mining company, for a total of $30.5 million, for paying approximately $15 million in bribes to Chilean officials. SQM agreed to a deferred prosecution agreement (DPA) with DOJ and to assignment of a two-year independent compliance monitor. The odd aspect of...

FCPA Recidivists: Orthofix (Part II of II)

In its continuing quest to push the message of aggressive FCPA enforcement, the SEC resolved FCPA charges against Orthofix, a medical device company, for $6 million in penalties and disgorgement. In a related action, the SEC announced that Orthofix and four executives agreed to pay $8 million for accounting control errors. The Justice Department declined to prosecute Orthofix. All of this sounds reasonable, except for...

Webinar: Lessons Learned from 2016 — Strategies to Improve Your Compliance Program

Lessons Learned from 2016 — Strategies to Improve Your Compliance Program Tuesday February 7th, 9AM PST/ 12 PM EST  SIGN UP HERE The United States Department of Justice and regulatory agencies continued to beat the drum on aggressive enforcement and the importance of compliance.  The Trump Administration is unlikely to alter this effort, except in certain areas like civil antitrust and environmental and labor regulation....

FCPA Recidivists: Zimmer Biomet (Part I of II)

It’s easier to fool people than to convince them they have been fooled – Mark Twain The drug and medical device industries have been taking it on the FCPA chin for years. The risk factors in the international marketplace are significant – (1) healthcare professionals are normally government employees; (2) government regulation of healthcare is robust; and (3) healthcare professionals are underpaid and therefore demand...

The “New” Face of Corporate Misconduct

As we look across the corporate governance landscape and focus on the spikes of corporate scandals, I started to wonder if there was any pattern or trend to the nature of corporate scandals. In the early 2000s, the country was rocked by financial accounting scandals and massive fraud in corporate reporting. In response, the Sarbanes-Oxley reforms were enacted, transforming the auditing and financial reporting requirements....